Suppr超能文献

1-苯并噻吩-3-基脲衍生物的合成及作为大麻素受体变构调节剂的药理学评价。

Synthesis and Pharmacological Evaluation of 1-Phenyl-3-Thiophenylurea Derivatives as Cannabinoid Type-1 Receptor Allosteric Modulators.

机构信息

Research Triangle Institute , Research Triangle Park , North Carolina 27709 , United States.

Department of Pharmacology and Toxicology , University of Buffalo, the State University of New York , Buffalo , New York 14214 , United States.

出版信息

J Med Chem. 2019 Nov 14;62(21):9806-9823. doi: 10.1021/acs.jmedchem.9b01161. Epub 2019 Oct 24.

Abstract

We previously reported diarylurea derivatives as cannabinoid type-1 receptor (CB) allosteric modulators, which were effective in attenuating cocaine-seeking behavior. Herein, we extended the structure-activity relationships of PSNCBAM-1 () at the central phenyl ring directly connected to the urea moiety. Replacement with a thiophene ring led to with improved or comparable potencies in calcium mobilization, [S]GTPγS binding, and cAMP assays, whereas substitution with nonaromatic rings led to significant attenuation of the modulatory activity. These compounds had no inverse agonism in [S]GTPγS binding, a characteristic that is often thought to contribute to adverse psychiatric effects. While had good metabolic stability in rat liver microsomes, it showed modest solubility and blood-brain barrier permeability. Compound showed an insignificant attenuation of cocaine seeking behavior in rats, most likely due to its limited CNS penetration, suggesting that pharmacokinetics and distribution play a role in translating the in vitro efficacy to in vivo behavior.

摘要

我们之前报道过二芳基脲衍生物是大麻素 1 型受体 (CB1) 的变构调节剂,能有效减轻可卡因觅药行为。在此,我们扩展了与脲部分直接相连的中央苯基环上的 PSNCBAM-1 () 的构效关系。用噻吩环取代得到了 ,其在钙动员、[S]GTPγS 结合和 cAMP 测定中具有改善或相当的效力,而用非芳环取代则显著降低了调节活性。这些化合物在 [S]GTPγS 结合中没有反向激动作用,这一特性通常被认为有助于产生不良的精神影响。虽然 在大鼠肝微粒体中具有良好的代谢稳定性,但它的溶解度和血脑屏障通透性较差。化合物 在大鼠中对可卡因觅药行为的抑制作用不明显,这很可能是由于其有限的中枢神经系统穿透性,表明药代动力学和分布在将体外疗效转化为体内行为方面发挥了作用。

相似文献

引用本文的文献

本文引用的文献

2
A patent update on cannabinoid receptor 1 antagonists (2015-2018).大麻素受体 1 拮抗剂专利更新(2015-2018)。
Expert Opin Ther Pat. 2019 Apr;29(4):261-269. doi: 10.1080/13543776.2019.1597851. Epub 2019 Apr 8.
4
PAM-Antagonists: A Better Way to Block Pathological Receptor Signaling?PAM 拮抗剂:阻断病理性受体信号的更好方法?
Trends Pharmacol Sci. 2018 Aug;39(8):748-765. doi: 10.1016/j.tips.2018.05.001. Epub 2018 Jun 7.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验